Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-50 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 |
filingDate |
2012-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-104024273-B |
titleOfInvention |
For treating the bifunctional protein of metabolic disease |
abstract |
The present invention relates to the new protein that discriminating comprises other metabolic modifiers of fibroblast growth factor (FGF21) and the known metabolism spectrum improving subject, including its variant.Also disclose for treating FGF21 relevant disease, GLP 1GLP 1 relevant disease and the method for exenatide relevant disease, including the metabolism patient's condition. |
priorityDate |
2011-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |